Skip to main content

Table 11 Characteristics of participants in included observational studies

From: Effectiveness and patient safety of platelet aggregation inhibitors in the prevention of cardiovascular disease and ischemic stroke in older adults – a systematic review

Reference

Country

Male sex

Age

Comorbidity

Number of coincident medications

Functional status/frailty level

Cognitive status

Burton 2006 [48]

Scotland

51%

Mean age 77 years, subgroup analysis age ≥ 75 years

Not reported

Not reported

Not reported

Not reported

Sam 2004 [59]

USA

49.8%

Men: mean age 72.5 years. Women: mean age 79 years, 100% older than 65 years

ASA/warfarin/none: congestive heart failure 14%/22%/65%, previous myocardial infarction 20%/18%/62%, stroke 25%/28%/46%, diabetes mellitus 25%/23%/53%, hypertension 21%/21%/58%, alcohol use 19%/26%/55%

Not reported

Not reported

Not reported

  1. Note: ACE angiotensin-converting-enzyme, ASA acetylsalicylic acid, AT Angiotensin, NSAID nonsteroidal anti-inflammatory drugs